Harrow Inc (HROW) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Harrow Inc   (NASDAQ: HROW)


Harrow Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Harrow Inc 's ROA in the second quarter of 2026?
Harrow Inc recorded a cumulative net loss of $-37 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -9.32%.

However, within the Healthcare sector 284 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2909, from total ROA ranking in the first quarter of 2026 at 3122.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 24.03 % 17.13 % -1.16 % 4.22 % 12.42 %
Y / Y Net Income Change - - -2.23 % - -
Net Income (TTM) in million -37 -15 -5 -5 -10
Return On Assets (TTM) -9.32 % -3.95 % -1.41 % -1.37 % -2.83 %
HROW's Total Ranking # 2909 # 3122 # 2753 # 2878 # 3139
Total Assets (TTM) in million 421 420 399 358 339
Seq. Total Assets Change 0.34 % 5.02 % 11.66 % 5.41 % -5.25 %
Seq. Net Income Change - - 549.61 % -79.58 % -

HROW's 5 Years Annual ROA >> Back to HROW Management Effectiveness >> Compare HROW ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 97
Sector # 285
Overall # 3139

Return On Assets Statistics
High Average Low
69.11 %
-31.03 %
-114.83 %
(Mar 31 2019)   (Dec 31 2015)



  News about Harrow Inc Return on Assets ROA

Harrows Strategic Vision Financial Growth, Global Engagement, and Expanding Horizons in Q3 2024,

Harrow Demonstrates Robust Growth and Strategic Expansion in Third Quarter 2024 Financial Report and Future Endeavors Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, has recently released its third quarter financial results for the period ending on September 30, 2024. In a strategic blend of past accomplishments and forward-looking initiatives, the company continues to solidify its position in the competitive pharmaceutical industry, focusing on ocular health. Stakeholders and interested parties are encouraged to explore the comprehensive details in Harrow s third quarter Letter to Stockholders and corporate presentation available on their website, harrow.com. Strong Third-Quarter PerformanceThe company s financial performance in the third quarter of 2024 indicates a robust phase of growth and profitability. Harrow s detailed release signifies not only positive financial results but also the successful execution of strategic initiatives within the eyecare pharmaceutical niche. The company s consistent focus on innovation and quality has contributed heavily to its financial success, marking an important milestone in its operational calendar.



Financial Statements
Harrow Inc 's Assets $ 421 million HROW's Balance sheet
Harrow Inc 's Income $ -17 million Quarterly HROW's Income Statement
HROW's Income by Division See HROW's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 4.39 % 24.15 % 103.05 % 59.04 % 80.59 %
Total Assets in million 399 383 308 152 95
Y / Y Net Income Change - - - - -
Net Income in million -5 -17 -24 -14 -18
Annual Return On Assets -1.29 % -4.57 % -7.92 % -9.28 % -18.87 %

HROW's 5 Years Annual ROA >> Back to HROW Management Effectiveness >> Compare HROW ROA to its Competitors



More Return On Assets Ratios
HROW's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HROW's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HROW's Competitors
Subscribers only: Roa for Harrow Inc 's Suppliers
Subscribers only: Return On Assets for HROW's Customers

You may also want to know
HROW's Roi HROW's Inventory Turnover Ratio HROW's Growth Rates HROW's Dividend Comparisons
HROW's Profitability Ratios HROW's Asset Turnover Ratio HROW's Dividend Growth
HROW's Roe HROW's Valuation Ratios HROW's Financial Strength Ratios HROW's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-26T07:04:03+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.